Market Exclusive

Analyst Activity – Royal Bank of Canada Reiterates Buy on Abbott Laboratories (NYSE:ABT)

Analyst Ratings For Abbott Laboratories (NYSE:ABT)

Today, Royal Bank of Canada reiterated its Buy rating on Abbott Laboratories (NYSE:ABT) with a price target of $67.00.

Some recent analyst ratings include

Dividend information for Abbott Laboratories (NYSE:ABT)

Abbott Laboratories (NYSE:ABT) pays an annual dividend of $1.12 with a yield of 1.77% and an average dividend growth of 6.40% based on a 3 Year Average..

Dividend History for Abbott Laboratories (NYSE:ABT)

Recent Insider Trading Activity For Abbott Laboratories (NYSE:ABT)
Abbott Laboratories (NYSE:ABT) has insider ownership of 0.76% and institutional ownership of 71.21%.

Recent Trading Activity for Abbott Laboratories (NYSE:ABT)
Shares of Abbott Laboratories closed the previous trading session at 63.35 up +1.62 2.62% with 62.33000183105469 shares trading hands.

Exit mobile version